News
Natalie Feagin, the executive director of the Clifton School, a day care that serves CDC and Emory employees at two locations ...
In 2008, Madeline “Kara” Neumann, age 11, died of diabetic ketoacidosis in Wisconsin. Her parents treated her symptoms with ...
Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, joining multiple biotech companies that have lost government funding for their ...
( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...
With Kennedy leading HHS, this about-face is easy to parse as yet another anti-vaccine move. But the assault on mRNA is also ...
Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...
RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...
Health Secretary Robert F. Kennedy Jr. has refused to acknowledge how his anti-vaccine rhetoric endangers public health ...
Public health workers and gun safety advocates gathered at a rally Tuesday night to commemorate last week’s deadly shooting near Emory University and the Centers for Disease Control and Prevention, ...
The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results